Pages that link to "Q41354495"

The following pages link to Validation of 4-[fluorine-18]fluoro-3-iodobenzylguanidine as a positron-emitting analog of MIBG. (Q41354495):

Displaying 11 items.

• PET/CT in paediatric malignancies - An update (Q28066175) (← links)
• Synthesis and evaluation of 4-[18F]fluoropropoxy-3-iodobenzylguanidine ([18F]FPOIBG): A novel 18F-labeled analogue of MIBG. (Q35782838) (← links)
• Assessment of cardiac sympathetic neuronal function using PET imaging (Q35912365) (← links)
• 3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells (Q36422723) (← links)
• EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma (Q36467722) (← links)
• (2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy (Q37722429) (← links)
• Synthesis and evaluation of 18F-labeled benzylguanidine analogs for targeting the human norepinephrine transporter (Q39068651) (← links)
• A 4-methyl-substituted meta-iodobenzylguanidine analogue with prolonged retention in human neuroblastoma cells (Q40543661) (← links)
• Scintigraphic evaluation of cardiac autonomic innervation (Q41111174) (← links)
• Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose (Q41224253) (← links)
• Harnessing Ionic Interactions and Hydrogen Bonding for Nucleophilic Fluorination (Q89658001) (← links)